Results 151 to 160 of about 3,693 (191)

Special Issue "Ion Channels as a Therapeutic Target: Drug Design and Pharmacological Investigation 2.0. [PDF]

Int J Mol Sci
Guerrini G, Giovannoni MP.
europepmc   +1 more source

Neonatal Pellagra. [PDF]

Clin Case Rep
Kitaoka H, Kakiuchi S.
europepmc   +1 more source

Episodic pain in Fabry disease is mediated by a heat shock protein-transient receptor potential cation channel A1 axis. [PDF]

Pain
Enders JD, Prodoehl EK, Sriram A, Penn SM, Stucky CL.   +4 more
europepmc   +1 more source

[Erythromelalgia].

Przeglad dermatologiczny, 1998
openaire   +1 more source

Severe tenosynovitis with rapidly fluctuating power Doppler activity, a clue for the diagnosis of Blau syndrome: a case report. [PDF]

Front Pediatr
Pastore S, Carraro C, De Martino E, Pin A, Bruno I, Zanotta N, Valencic E, Tommasini A, Taddio A.   +8 more
europepmc   +1 more source

Erythromelalgia

, 2022
openaire   +1 more source

Candidate SNP markers of changes in the expression levels of the human SCN9A gene as a hub gene for pain generation, perception, response and anesthesia. [PDF]

Vavilovskii Zhurnal Genet Selektsii
Dotsenko PA, Zolotareva KA, Ivanov RA, Chadaeva IV, Podkolodnyy NL, Ivanisenko VA, Demenkov PS, Lashin SA, Ponomarenko MP.   +8 more
europepmc   +1 more source

Clinical Efficacy and Safety Profile of Suzetrigine: A Novel Non-opioid Analgesic Targeting NaV1.8 Sodium Channel. [PDF]

Cureus
Rejeev MM, Pavithran K, Palatty P.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Erythromelalgia

Current Treatment Options in Cardiovascular Medicine, 2002
No treatment is consistently effective in the management of patients with erythromelalgia. There is a dearth of adequate studies examining the response of erythromelalgia to therapy. Most recommendations are suggested based on case reports, small case series, and anecdotal reports.
Mark D P, Davis, Thom, Rooke
openaire   +5 more sources